Ophthalmic and Topical Dosage Form New Animal Drugs; Imidacloprid and Moxidectin
other · Food and Drug Administration · Rule · Published 2007-03-09 · Effective 2007-03-09 · 72 FR 10597
Document
Document number
E7-4226
Federal Register citation
72 FR 10597
CFR reference
21 CFR 524
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2007-03-09
Effective date
2007-03-09
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two new animal drug applications (NADAs) filed by Bayer HealthCare LLC. The NADAs provide for the topical use by veterinary prescription of topical solutions containing imidacloprid and two strengths of moxidectin, one for use on dogs and the other for use on cats, for the prevention of heartworm disease, the treatment of flea infestations, and the treatment and control of several internal parasites.